Rivaroxaban Prophylaxis in Peripherally Inserted Central Catheter-Related Thrombosis in Breast Cancer Patients
Two months of rivaroxaban prophylaxis effectively and safely reduce CRT incidence in breast cancer patients with PICC.
Authors
- Huimin Feng (ORCID: https://orcid.org/0000-0002-6150-4371)
- Die Sang (ORCID: https://orcid.org/0009-0001-9637-4220)
- Peng Yuan (ORCID: https://orcid.org/0000-0003-3019-0688)
- Yinfeng Wang (ORCID: https://orcid.org/0009-0002-2002-3202)
- Xiaoyan Zhang (ORCID: https://orcid.org/0000-0001-5179-1488)
- Man Li (ORCID: https://orcid.org/0000-0002-7480-0401)
- Shiyu Li (ORCID: https://orcid.org/0000-0002-9554-198X)
- Jintao Zhang (ORCID: https://orcid.org/0000-0002-1309-6836)
- Yujuan Liu (ORCID: https://orcid.org/0000-0003-1980-1871)
- Yanfang Su
- Yuzhi Hao
- Shanmin Fan
Institutions
- Dalian Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Cancer Center (US)
- Second Affiliated Hospital of Dalian Medical University (CN)
- Cancer Hospital of Huanxing Chaoyang District Beijing (CN)
Publication Details
- Journal
- Archives of Medical Research
- Published
- 2025-06-07
- DOI
- https://doi.org/10.1016/j.arcmed.2025.103242
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences